These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1079 related articles for article (PubMed ID: 32981333)

  • 1. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
    Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
    J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
    Uncini A; Vallat JM; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
    Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
    Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
    Agha Abbaslou M; Karbasi M; Mozhdehipanah H
    Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
    Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
    Diez-Porras L; Vergés E; Gil F; Vidal MJ; Massons J; Arboix A
    Neuromuscul Disord; 2020 Oct; 30(10):859-861. PubMed ID: 32912716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.
    Wada S; Nagasaki Y; Arimizu Y; Shimo M; Matsukuma Y; Okamoto M; Yoshida S; Ohashi I; Hashimoto G; Kuwashiro T; Yasaka M; Okada Y
    Intern Med; 2020 Sep; 59(17):2187-2189. PubMed ID: 32713924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection.
    Chan JL; Ebadi H; Sarna JR
    Can J Neurol Sci; 2020 Nov; 47(6):852-854. PubMed ID: 32468972
    [No Abstract]   [Full Text] [Related]  

  • 10. Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
    Sancho-Saldaña A; Lambea-Gil Á; Liesa JLC; Caballo MRB; Garay MH; Celada DR; Serrano-Ponz M
    Clin Med (Lond); 2020 Jul; 20(4):e93-e94. PubMed ID: 32518103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital.
    Ottaviani D; Boso F; Tranquillini E; Gapeni I; Pedrotti G; Cozzio S; Guarrera GM; Giometto B
    Neurol Sci; 2020 Jun; 41(6):1351-1354. PubMed ID: 32399950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome associated with COVID-19 disease.
    Korem S; Gandhi H; Dayag DB
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32958554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.
    Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32518172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome after COVID-19 in Japan.
    Hirayama T; Hongo Y; Kaida K; Kano O
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33122241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
    Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
    Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain Barre syndrome associated with COVID-19 infection: A case report.
    Sedaghat Z; Karimi N
    J Clin Neurosci; 2020 Jun; 76():233-235. PubMed ID: 32312628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome presenting with COVID-19 infection.
    Ameer N; Shekhda KM; Cheesman A
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32928835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post SARS-CoV-2 Guillain-Barré syndrome.
    Arnaud S; Budowski C; Ng Wing Tin S; Degos B
    Clin Neurophysiol; 2020 Jul; 131(7):1652-1654. PubMed ID: 32422529
    [No Abstract]   [Full Text] [Related]  

  • 19. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
    Juliao Caamaño DS; Alonso Beato R
    J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
    Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
    Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.